TAGS: Skin Care
Natural/ Organic
Avicanna has announced the results from its first cosmetic clinical study, an open-label, randomized, passive-control study examining the impact of its Pura Earth™ topical cream containing 0.5 percent cannabidiol and 1 percent hemp oil on skin hydration.
Demonstrated Efficacy of Cannabidiol Cream
The company has successfully completed the first of three clinical studies for selected products from Pura Earth derma-cosmetics line of CBD products. The results of this study demonstrated the safety and efficacy of the Pura Earth cannabidiol cream.
“
In particular, we achieved the primary end point of enhanced skin hydration. The new data builds upon the R&D data generated for our Pura Earth product line, and further supports our belief that this particular formulation of cannabidiol has potential efficacy in the treatment of cutaneous diseases,” stated Dr. Daniel Sauder (Chair of Avicanna’s Dermatology Expert Committee).
No Adverse Effects were Reported
Of the total 61 subjects enrolled, 49 healthy adults with modified Kligman test (i.e., dry skin) successfully completed the study. No adverse effects that required medical intervention or discontinuation were reported during the period of the study.
“
The investments that we’ve made in the research and development of the Pura Earth products is validated by these positive clinical results and further elevates the brand in the CBD derma-cosmetics market. As a result, we are setting a new industry standard that will help us earn the trust of retailers and customers as we expand the retail launch of Pura Earth across additional geographies in 2020,” commented Aras Azadian, chief executive officer of Avicanna.
The Pura Earth products were produced with Avicanna’s proprietary formulations using cannabidiol (“CBD“) isolate extracted by the Company’s majority owned subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH“), from cannabis grown and cultivated by SMGH in Santa Marta, Colombia. SMGH’s CBD isolate is derived from its USDA organic certified hemp (non-psychoactive cannabis).
“
We have developed our products through our leading cannabinoid research labs in Canada with the goal of offering over-the-counter products backed by evidence. In addition, we have established strict quality controls across our vertically integrated operations that allow us to offer a consistent, quality product to our customers,” added Azadian.
This study was conducted by CAIMED S.A.S. Medical Care and Research Center in Bogota, Colombia. Avicanna plans to present additional detailed data from the study at upcoming medical conferences and in peer-reviewed publications.
In addition, CAIMED has completed two additional studies for Avicanna: a study evaluating the effect of a facial cream containing 0.5 percent cannabidiol and 1 percent hemp oil on skin hydration and characteristics associated with acne-prone skin; and, a study evaluating the effect of a topical serum preparation containing 1 percent cannabidiol and apple stem cells on skin characteristics associated with aging. The Company plans on announcing top-line results from both studies once the data is compiled.
Source: Avicanna